Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma

Academic Article

Abstract

  • Renal medullary carcinoma (RMC) is a rare and aggressive malignancy seen primarily in patients with sickle-cell trait. We report a complete response to carboplatin, paclitaxel, and gemcitabine in a patient with advanced metastatic RMC. © 2010 Wiley-Liss, Inc.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Walsh A; Kelly DR; Vaid YN; Hilliard LM; Friedman GK
  • Start Page

  • 1217
  • End Page

  • 1220
  • Volume

  • 55
  • Issue

  • 6